Myeloperoxidase Exocytosis from Activated Neutrophils in the Presence of Heparin

Exocytosis of myeloperoxidase (MPO) from activated neutrophils has been investigated in the presence of the anionic polysaccharide heparin. The optimal concentration of heparin (0.1 U/mL), which did not cause additional activation of cells (lack of augmentation of lysozyme exocytosis from specific a...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Biochemistry (Moscow). Supplement. Series B, Biomedical chemistry Biomedical chemistry, 2018-04, Vol.12 (2), p.136-142
Hauptverfasser: Grigorieva, D. V., Gorudko, I. V., Kostevich, V. A., Vasilyev, V. B., Cherenkevich, S. N., Panasenko, O. M., Sokolov, A. V.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 142
container_issue 2
container_start_page 136
container_title Biochemistry (Moscow). Supplement. Series B, Biomedical chemistry
container_volume 12
creator Grigorieva, D. V.
Gorudko, I. V.
Kostevich, V. A.
Vasilyev, V. B.
Cherenkevich, S. N.
Panasenko, O. M.
Sokolov, A. V.
description Exocytosis of myeloperoxidase (MPO) from activated neutrophils has been investigated in the presence of the anionic polysaccharide heparin. The optimal concentration of heparin (0.1 U/mL), which did not cause additional activation of cells (lack of augmentation of lysozyme exocytosis from specific and azurophilic granules), was determined. After preincubation of cells with heparin (0.1 U/mL) MPO exocytosis from neutrophils was stimulated by various activators (fMLP, PMA, plant lectins CABA and PHA-L) and was higher as compared to the effects of the activators alone. Experiments performed using MPO isolated from leukocytes have shown that heparin in the range of concentrations 0.1–50 U/mL had no effect on MPO peroxidase activity. Thus, the use of heparin at a concentration of 0.1 U/mL avoids the artifact caused by the “loss” of MPO due to its binding to neutrophils and increases the accuracy of the method of registration of degranulation of neutrophil azurophilic granules based on determination of the MPO concentration or its peroxidase activity in cell supernatants.
doi_str_mv 10.1134/S199075081802004X
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2047017715</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2047017715</sourcerecordid><originalsourceid>FETCH-LOGICAL-c268t-748241291b1ea10b9bf56dda8ef68c2a852d9d4976c75dba73705bec6660b75e3</originalsourceid><addsrcrecordid>eNp1kE1Lw0AQhhdRsFZ_gLcFz9HZTfYjx1KqFaoWVPAWNpuJTWmzcXcr7b83paIH8TTD8DzvwEvIJYNrxtLs5pnlOSgBmmngANnbERnsT4kSTB7_7KBPyVkISwDJ0jwbkPnDDleuQ--2TWUC0snW2V10oQm09m5NRzY2nyZiRR9xE73rFs0q0KalcYF07jFga5G6mk6xM75pz8lJbVYBL77nkLzeTl7G02T2dHc_Hs0Sy6WOico0zxjPWcnQMCjzshayqozGWmrLjRa8yqssV9IqUZVGpQpEiVZKCaUSmA7J1SG38-5jgyEWS7fxbf-y4JApYEox0VPsQFnvQvBYF51v1sbvCgbFvrjiT3G9ww9O6Nn2Hf1v8v_SF5B3b_8</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2047017715</pqid></control><display><type>article</type><title>Myeloperoxidase Exocytosis from Activated Neutrophils in the Presence of Heparin</title><source>SpringerLink Journals</source><creator>Grigorieva, D. V. ; Gorudko, I. V. ; Kostevich, V. A. ; Vasilyev, V. B. ; Cherenkevich, S. N. ; Panasenko, O. M. ; Sokolov, A. V.</creator><creatorcontrib>Grigorieva, D. V. ; Gorudko, I. V. ; Kostevich, V. A. ; Vasilyev, V. B. ; Cherenkevich, S. N. ; Panasenko, O. M. ; Sokolov, A. V.</creatorcontrib><description>Exocytosis of myeloperoxidase (MPO) from activated neutrophils has been investigated in the presence of the anionic polysaccharide heparin. The optimal concentration of heparin (0.1 U/mL), which did not cause additional activation of cells (lack of augmentation of lysozyme exocytosis from specific and azurophilic granules), was determined. After preincubation of cells with heparin (0.1 U/mL) MPO exocytosis from neutrophils was stimulated by various activators (fMLP, PMA, plant lectins CABA and PHA-L) and was higher as compared to the effects of the activators alone. Experiments performed using MPO isolated from leukocytes have shown that heparin in the range of concentrations 0.1–50 U/mL had no effect on MPO peroxidase activity. Thus, the use of heparin at a concentration of 0.1 U/mL avoids the artifact caused by the “loss” of MPO due to its binding to neutrophils and increases the accuracy of the method of registration of degranulation of neutrophil azurophilic granules based on determination of the MPO concentration or its peroxidase activity in cell supernatants.</description><identifier>ISSN: 1990-7508</identifier><identifier>EISSN: 1990-7516</identifier><identifier>DOI: 10.1134/S199075081802004X</identifier><language>eng</language><publisher>Moscow: Pleiades Publishing</publisher><subject>Anticoagulants ; Bioorganic Chemistry ; Chemistry ; Chemistry and Materials Science ; Degranulation ; Exocytosis ; Formyl peptides ; Heparin ; Lectins ; Leukocytes (neutrophilic) ; Lysozyme ; Medicinal Chemistry ; Neutrophils ; Peroxidase ; Polysaccharides</subject><ispartof>Biochemistry (Moscow). Supplement. Series B, Biomedical chemistry, 2018-04, Vol.12 (2), p.136-142</ispartof><rights>Pleiades Publishing, Ltd. 2018</rights><rights>Biochemistry (Moscow), Supplement Series B: Biomedical Chemistry is a copyright of Springer, (2018). All Rights Reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c268t-748241291b1ea10b9bf56dda8ef68c2a852d9d4976c75dba73705bec6660b75e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1134/S199075081802004X$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1134/S199075081802004X$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,27901,27902,41464,42533,51294</link.rule.ids></links><search><creatorcontrib>Grigorieva, D. V.</creatorcontrib><creatorcontrib>Gorudko, I. V.</creatorcontrib><creatorcontrib>Kostevich, V. A.</creatorcontrib><creatorcontrib>Vasilyev, V. B.</creatorcontrib><creatorcontrib>Cherenkevich, S. N.</creatorcontrib><creatorcontrib>Panasenko, O. M.</creatorcontrib><creatorcontrib>Sokolov, A. V.</creatorcontrib><title>Myeloperoxidase Exocytosis from Activated Neutrophils in the Presence of Heparin</title><title>Biochemistry (Moscow). Supplement. Series B, Biomedical chemistry</title><addtitle>Biochem. Moscow Suppl. Ser. B</addtitle><description>Exocytosis of myeloperoxidase (MPO) from activated neutrophils has been investigated in the presence of the anionic polysaccharide heparin. The optimal concentration of heparin (0.1 U/mL), which did not cause additional activation of cells (lack of augmentation of lysozyme exocytosis from specific and azurophilic granules), was determined. After preincubation of cells with heparin (0.1 U/mL) MPO exocytosis from neutrophils was stimulated by various activators (fMLP, PMA, plant lectins CABA and PHA-L) and was higher as compared to the effects of the activators alone. Experiments performed using MPO isolated from leukocytes have shown that heparin in the range of concentrations 0.1–50 U/mL had no effect on MPO peroxidase activity. Thus, the use of heparin at a concentration of 0.1 U/mL avoids the artifact caused by the “loss” of MPO due to its binding to neutrophils and increases the accuracy of the method of registration of degranulation of neutrophil azurophilic granules based on determination of the MPO concentration or its peroxidase activity in cell supernatants.</description><subject>Anticoagulants</subject><subject>Bioorganic Chemistry</subject><subject>Chemistry</subject><subject>Chemistry and Materials Science</subject><subject>Degranulation</subject><subject>Exocytosis</subject><subject>Formyl peptides</subject><subject>Heparin</subject><subject>Lectins</subject><subject>Leukocytes (neutrophilic)</subject><subject>Lysozyme</subject><subject>Medicinal Chemistry</subject><subject>Neutrophils</subject><subject>Peroxidase</subject><subject>Polysaccharides</subject><issn>1990-7508</issn><issn>1990-7516</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>BENPR</sourceid><recordid>eNp1kE1Lw0AQhhdRsFZ_gLcFz9HZTfYjx1KqFaoWVPAWNpuJTWmzcXcr7b83paIH8TTD8DzvwEvIJYNrxtLs5pnlOSgBmmngANnbERnsT4kSTB7_7KBPyVkISwDJ0jwbkPnDDleuQ--2TWUC0snW2V10oQm09m5NRzY2nyZiRR9xE73rFs0q0KalcYF07jFga5G6mk6xM75pz8lJbVYBL77nkLzeTl7G02T2dHc_Hs0Sy6WOico0zxjPWcnQMCjzshayqozGWmrLjRa8yqssV9IqUZVGpQpEiVZKCaUSmA7J1SG38-5jgyEWS7fxbf-y4JApYEox0VPsQFnvQvBYF51v1sbvCgbFvrjiT3G9ww9O6Nn2Hf1v8v_SF5B3b_8</recordid><startdate>20180401</startdate><enddate>20180401</enddate><creator>Grigorieva, D. V.</creator><creator>Gorudko, I. V.</creator><creator>Kostevich, V. A.</creator><creator>Vasilyev, V. B.</creator><creator>Cherenkevich, S. N.</creator><creator>Panasenko, O. M.</creator><creator>Sokolov, A. V.</creator><general>Pleiades Publishing</general><general>Springer Nature B.V</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88I</scope><scope>8AO</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M2P</scope><scope>M7P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope></search><sort><creationdate>20180401</creationdate><title>Myeloperoxidase Exocytosis from Activated Neutrophils in the Presence of Heparin</title><author>Grigorieva, D. V. ; Gorudko, I. V. ; Kostevich, V. A. ; Vasilyev, V. B. ; Cherenkevich, S. N. ; Panasenko, O. M. ; Sokolov, A. V.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c268t-748241291b1ea10b9bf56dda8ef68c2a852d9d4976c75dba73705bec6660b75e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Anticoagulants</topic><topic>Bioorganic Chemistry</topic><topic>Chemistry</topic><topic>Chemistry and Materials Science</topic><topic>Degranulation</topic><topic>Exocytosis</topic><topic>Formyl peptides</topic><topic>Heparin</topic><topic>Lectins</topic><topic>Leukocytes (neutrophilic)</topic><topic>Lysozyme</topic><topic>Medicinal Chemistry</topic><topic>Neutrophils</topic><topic>Peroxidase</topic><topic>Polysaccharides</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Grigorieva, D. V.</creatorcontrib><creatorcontrib>Gorudko, I. V.</creatorcontrib><creatorcontrib>Kostevich, V. A.</creatorcontrib><creatorcontrib>Vasilyev, V. B.</creatorcontrib><creatorcontrib>Cherenkevich, S. N.</creatorcontrib><creatorcontrib>Panasenko, O. M.</creatorcontrib><creatorcontrib>Sokolov, A. V.</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Science Database</collection><collection>Biological Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><jtitle>Biochemistry (Moscow). Supplement. Series B, Biomedical chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Grigorieva, D. V.</au><au>Gorudko, I. V.</au><au>Kostevich, V. A.</au><au>Vasilyev, V. B.</au><au>Cherenkevich, S. N.</au><au>Panasenko, O. M.</au><au>Sokolov, A. V.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Myeloperoxidase Exocytosis from Activated Neutrophils in the Presence of Heparin</atitle><jtitle>Biochemistry (Moscow). Supplement. Series B, Biomedical chemistry</jtitle><stitle>Biochem. Moscow Suppl. Ser. B</stitle><date>2018-04-01</date><risdate>2018</risdate><volume>12</volume><issue>2</issue><spage>136</spage><epage>142</epage><pages>136-142</pages><issn>1990-7508</issn><eissn>1990-7516</eissn><abstract>Exocytosis of myeloperoxidase (MPO) from activated neutrophils has been investigated in the presence of the anionic polysaccharide heparin. The optimal concentration of heparin (0.1 U/mL), which did not cause additional activation of cells (lack of augmentation of lysozyme exocytosis from specific and azurophilic granules), was determined. After preincubation of cells with heparin (0.1 U/mL) MPO exocytosis from neutrophils was stimulated by various activators (fMLP, PMA, plant lectins CABA and PHA-L) and was higher as compared to the effects of the activators alone. Experiments performed using MPO isolated from leukocytes have shown that heparin in the range of concentrations 0.1–50 U/mL had no effect on MPO peroxidase activity. Thus, the use of heparin at a concentration of 0.1 U/mL avoids the artifact caused by the “loss” of MPO due to its binding to neutrophils and increases the accuracy of the method of registration of degranulation of neutrophil azurophilic granules based on determination of the MPO concentration or its peroxidase activity in cell supernatants.</abstract><cop>Moscow</cop><pub>Pleiades Publishing</pub><doi>10.1134/S199075081802004X</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1990-7508
ispartof Biochemistry (Moscow). Supplement. Series B, Biomedical chemistry, 2018-04, Vol.12 (2), p.136-142
issn 1990-7508
1990-7516
language eng
recordid cdi_proquest_journals_2047017715
source SpringerLink Journals
subjects Anticoagulants
Bioorganic Chemistry
Chemistry
Chemistry and Materials Science
Degranulation
Exocytosis
Formyl peptides
Heparin
Lectins
Leukocytes (neutrophilic)
Lysozyme
Medicinal Chemistry
Neutrophils
Peroxidase
Polysaccharides
title Myeloperoxidase Exocytosis from Activated Neutrophils in the Presence of Heparin
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-13T01%3A18%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Myeloperoxidase%20Exocytosis%20from%20Activated%20Neutrophils%20in%20the%20Presence%20of%20Heparin&rft.jtitle=Biochemistry%20(Moscow).%20Supplement.%20Series%20B,%20Biomedical%20chemistry&rft.au=Grigorieva,%20D.%20V.&rft.date=2018-04-01&rft.volume=12&rft.issue=2&rft.spage=136&rft.epage=142&rft.pages=136-142&rft.issn=1990-7508&rft.eissn=1990-7516&rft_id=info:doi/10.1134/S199075081802004X&rft_dat=%3Cproquest_cross%3E2047017715%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2047017715&rft_id=info:pmid/&rfr_iscdi=true